Anthropometric improvements, such as reduction in waist circumference and total fat percentage, were consistently observed following GLP-1 RA therapy [31,37], indicating potential benefits for cardio-metabolic health in PCOS patients. This evidence concerns the gene GCG and polycystic ovary syndrome.